The expression of MAGE-C1/CT7 was the most useful indictor in patients with MM, while MAGE-A3 and MAGE-C2/CT10 might confer an additive value for the prediction of disease complications and prognosis. Here, MAGEC2 is linked to Miyoshi myopathy.